Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Treatment of Pediatric Hypertension With Altace Trial

ClinicalTrials.gov ID: NCT00044265

Public ClinicalTrials.gov record NCT00044265. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 5:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Dose Escalation, Randomized, Double-blind Withdrawal Study of the Efficacy, Dose-response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Ramipril is an ACE inhibitor that has been marketed in the US for the treatment of hypertension since 1991. It has been shown to be effective in reducing both systolic and diastolic blood pressure in adults when used once daily. ACE inhibitors are frequently used to treat hypertension in children, however ramipril has not been extensively tested in children, and information regarding the efficacy and safety would therefore be of benefit to children. This study is designed to demonstrate the efficacy and safety of ramipril in the treatment of hypertension in children ages 6 through 16 years.

Study identification

NCT ID
NCT00044265
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
310 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2002
Primary completion
Not listed
Completion
Oct 31, 2004
Last update posted
Jun 6, 2012

2002 – 2004

United States locations

U.S. sites
30
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
Sante Los Angeles Los Angeles California 90010
Neufeld Medical Group Los Angeles California 90048
UCLA Medical Center Los Angeles California 90095
Medical College of Georgia Augusta Georgia 30912
Kapiolani Medical Center for Women and Children Honolulu Hawaii 96813
Nephrology and Hypertension Consultants Park Ridge Illinois 60068
University of Louisville Louisville Kentucky 40202
Tulane University Health Sciences Center New Orleans Louisiana 70112
University of Maryland Baltimore Maryland 21201
Children's Hospital of Michigan Detroit Michigan 48201
Univ of Missouri, Children's Mercy Hospital and Clinics Kansas City Missouri 64108
St. Louis Children's Hospital St Louis Missouri 63110
North Shore Univ Hospital c/o BRANY Great Neck New York 11021
Montefiore Medical Center c/o BRANY The Bronx New York 10467
Children's Hospital Medical Center Cincinnati Ohio 45229
University Hospitals of Cleveland Cleveland Ohio 44106
Cleveland Clinic Foundation Cleveland Ohio 44195
PCTI at Columbus Children's Hospital Columbus Ohio 43205
Oregon Health and Science University Portland Oregon 97201
Hershey Medical Center Hershey Pennsylvania 17033
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
The Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
Le Bonheur Children's Hospital - Univ of Tennessee Memphis Tennessee 38103
Vanderbilt University Medical Center Nashville Tennessee 37232
Texas Children's Hospital Houston Texas 77030
University of Texas Medical Center Houston Texas 77030
University of Virginia Charlottesville Virginia 22908
University of Wisconsin Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00044265, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 6, 2012 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00044265 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →